| Structure |
Chemical Name |
CAS |
MF |
 |
Sugammadex sodium Heptabromide intermediate |
|
|
 |
Rabacfosadine succinate |
1431856-99-3 |
C25H41N8O10P |
 |
Cefotiam (6R,7S) isomer reference |
|
|
 |
4-TERT-BUTOXYCARBONYLAMINO-PIPERIDINE-1,4-DICARBOXYLIC ACID MONOBENZYL ESTER |
252720-32-4 |
C19H26N2O6 |
 |
Engelide intermediate |
|
|
 |
Ethyl 4-acetoxy-6,7-difluoro-2-(ethylthio)quinoline-3-carboxylate |
154330-68-4 |
C16H15F2NO4S |
![(5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride](/CAS/20180703/GIF/1373116-04-1.gif) |
(5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride |
1373116-04-1 |
C25H37ClF2N2OSi |
 |
Cefiderocol |
1225208-94-5 |
C30H34ClN7O10S2 |
 |
2,3-Dimethylbenzyl alcohol |
13651-14-4 |
C9H12O |
 |
(1R)-(+)-TRANS-PINANE |
4863-59-6 |
C10H18 |
 |
(3R,4S)-1-((Benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid |
1428243-24-6 |
C15H19NO4 |
 |
5-Methyl-4-isoxazolecarboxylic acid |
42831-50-5 |
C5H5NO3 |
 |
13,14-DIHYDRO-15-KETO PROSTAGLANDIN E2 |
363-23-5 |
C20H32O5 |
![1-acetyl-3-[((2r)-1-methylpyrrolidin-2-yl)methyl]-5-[(e)-2-(phenylsulfonyl)vinyl]indole](/CAS/GIF/188113-71-5.gif) |
1-acetyl-3-[((2r)-1-methylpyrrolidin-2-yl)methyl]-5-[(e)-2-(phenylsulfonyl)vinyl]indole |
188113-71-5 |
C24H26N2O3S |
 |
5'-Methoxylaudanosine |
24734-71-2 |
C22H29NO5 |
 |
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone |
530084-79-8 |
C18H16BrNO3 |
 |
Prostaglandin F3a |
|
|
 |
8-iso Prostaglandin F2a-d4 |
|
|
 |
Bis(4-isopropylphenyl)iodonium chloride |
97671-66-4 |
C18H22ClI |
 |
(3S,4R,5R)-Oseltamivir |
|
|
![4-Benzo[b]thien-2-ylbenzenamine](/CAS/20200611/GIF/54492-95-4.gif) |
4-Benzo[b]thien-2-ylbenzenamine |
54492-95-4 |
C14H11NS |
 |
(S)-3-Amino-3-(4-chlorophenyl)propan-1-ol |
886061-26-3 |
C9H12ClNO |
 |
Silicone intermediate |
|
|
![7-Chloro-1H-pyrrolo[3,2-b]pyridine](/CAS/GIF/357263-48-0.gif) |
7-Chloro-1H-pyrrolo[3,2-b]pyridine |
357263-48-0 |
C7H5ClN2 |
![[[(1a,3b,5Z,7E)-25-[(Tetrahydro-2H-pyran-2-yl)oxy]-9,10-secocholesta-5,7,10(19)-triene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethylsilane]](/CAS/GIF/211866-07-8.gif) |
[[(1a,3b,5Z,7E)-25-[(Tetrahydro-2H-pyran-2-yl)oxy]-9,10-secocholesta-5,7,10(19)-triene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethylsilane] |
211866-07-8 |
C44H80O4Si2 |
 |
4-AMINO-CHROMEN-2-ONE |
53348-92-8 |
C9H7NO2 |
![[402960-19-4],C9H18N2O2, 186.40](/CAS/20180808/GIF/850252-34-5.gif) |
[402960-19-4],C9H18N2O2, 186.40 |
850252-34-5 |
C9H19ClN2O2 |
 |
1375471-12-7 |
1375471-12-7 |
C19H22F6N2O3 |
 |
Ibrexafungerp Intermediate |
1140751-11-6 |
C31H50O5 |
 |
Ceftiofur Double Mother Nucleus |
|
|
 |
Cefixime Dimer D |
|
|
 |
7S-Cephalexin |
|
|
 |
(6R,7S)-Latamoxef MotherNucleus |
|
|
 |
COUMARIN 6 |
88241-65-0 |
C15H12O2 |
 |
5-Bromopentan-1-ol |
34626-51-2 |
C5H11BrO |
 |
FLUTICASONE PROPIONATE INTERMEDIATE |
80474-45-9 |
C24H30F2O5S |
 |
2-Chloro-5-methylpyrazine |
59303-10-5 |
C5H5ClN2 |
 |
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol |
142569-70-8 |
C29H28ClNO2 |
 |
1,3-Benzodioxole-5-acetic acid methyl ester |
326-59-0 |
C10H10O4 |
![1H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-](/CAS/20210305/GIF/2212021-81-1.gif) |
1H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]- |
2212021-81-1 |
C28H31N3O2 |
 |
cytidylyl-(5'->3')-guanosine |
4785-04-0 |
C19H25N8O12P |
![(6R-trans)-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](/CAS/GIF/58233-18-4.gif) |
(6R-trans)-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
58233-18-4 |
C15H16N4O6S2 |
 |
5,5'-methylenebis(1H-benzotriazole) |
15805-10-4 |
C13H10N6 |
 |
4-(dimethylammonio)piperidinium dichloride |
4876-59-9 |
C7H18Cl2N2 |
 |
Dolutegravir intermediate |
|
|
 |
(7S)-Cefuroxime |
|
|
 |
5-phenyl-2,3,7-tris(phenylamino)phenazinium chloride |
4935-81-3 |
C36H28ClN5 |
 |
4-chloro-1-(dichloromethyl)benzene |
13940-94-8 |
C7H5Cl3 |
 |
6,7-DIHYDROXY-4-(TRIFLUOROMETHYL)COUMARIN |
82747-36-2 |
C10H5F3O4 |
 |
455284-06-7 |
455284-06-7 |
|
 |
N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide |
122584-18-3 |
C17H18BrNO4 |
 |
4-Chlorodehydromethyltestosterone |
2446-23-3 |
C20H27ClO2 |
 |
2'-iodo-2'-deoxyuridine |
4753-03-1 |
C9H11IN2O5 |
![(1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane](/CAS/20180808/GIF/110567-22-1.gif) |
(1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane |
110567-22-1 |
C20H22O3 |
 |
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate |
900186-73-4 |
C26H26N2O5 |
 |
Coumarin |
10172-75-5 |
C26H18O7 |
 |
PROSTAGLANDIN H2 |
42935-17-1 |
C20H32O5 |
 |
2,4-dihydroxy-6-propyl-benzoic acid methyl ester |
55382-52-0 |
C11H14O4 |
 |
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate |
1050477-44-5 |
C24H24N4O4 |
 |
tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate |
474645-25-5 |
C40H59N3O7 |
 |
1-Vinylimidazole |
1072-63-5 |
C5H6N2 |
 |
2'-CHLORO-2'-DEOXYURIDINE |
4753-04-2 |
C9H11ClN2O5 |
 |
FMOC-21-AMINO-4,7,10,13,16,19-HEXAOXAHENEICOSANOIC ACID |
882847-34-9 |
C30H41NO10 |
 |
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA |
27376-76-7 |
C20H34O5 |
 |
Posaconazole Impurity 16 |
213381-02-3 |
C37H42F2N8O4 |
 |
4,7-DIMETHYLCOUMARIN |
14002-90-5 |
C11H10O2 |
 |
5-Fluoroindole |
399-52-0 |
C8H6FN |
 |
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
182182-31-6 |
C13H15FN2O2 |
 |
5-BRDU 5-bromo-2'-deoxyuridine |
|
|
 |
tetramethyl 3,3',3'',3'''-(porphyrin-5,10,15,20-tetrayl)tetrabenzoate |
75286-83-8 |
C52H38N4O8 |
 |
7-Chloro-1,2,3,4-tetrahydrobenzo(b)azepin-5-one |
160129-45-3 |
C10H10ClNO |
 |
4-methyl-7-nitro- 2H-chromen-2-one |
179897-88-2 |
C10H7NO4 |
 |
Ceftizoxime Impurity 19 |
64918-77-0 |
C7H8N2O4S |
 |
Cefradine double nucleus |
|
|
 |
Fulvestrant intermediate |
1610351-44-4 |
C30H46O6S |
 |
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole |
97963-62-7 |
C8H6F2N2OS |
 |
ADENYLYL(3'>5')CYTIDINE FREE ACID |
2382-66-3 |
C19H25N8O11P |
 |
CEFMETAZOLE MMT ISOMER |
|
|
 |
Cyclobutanecarboxylic acid, 3-(methylamino)-, 1-methylethyl ester, cis- |
2136718-64-2 |
C9H17NO2 |
 |
Vanadyl Riboside Complex (RVC/VRC) |
|
|
 |
Cefminox for system suitability |
|
|
 |
Flomoxef Intermediate NaMT |
|
|
 |
3,4-(Methylenedioxy)aniline |
14268-66-7 |
C7H7NO2 |
 |
Methenolone enanthate |
303-42-4 |
C27H42O3 |
 |
8-OXO-DG |
|
|
![Pyrazolo[1,5-a]pyridine-3-carbonitrile, 4-(6-fluoro-3-pyridinyl)-6-hydroxy-](/CAS/20181212/GIF/2222654-09-1.gif) |
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 4-(6-fluoro-3-pyridinyl)-6-hydroxy- |
2222654-09-1 |
C13H7FN4O |
 |
1-chloro-8-phenyl-Dibenzofuran |
2379717-75-4 |
C18H11ClO |
![2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid](/) |
2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid |
|
|
 |
3,20-bis(ethylenedioxy)pregna-5,7-diene |
19592-55-3 |
C25H36O4 |
 |
Isopropyl 2-((5-amino-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate |
1847465-25-1 |
C29H37N7O3 |
 |
7-amino-3-phenyl-2-benzopyrone |
4108-61-6 |
C15H11NO2 |
 |
methyl ibogamine-18-carboxylate |
467-77-6 |
C21H26N2O2 |
 |
4-Methylcumarin |
607-71-6 |
C10H8O2 |
 |
Dabigatran intermediate |
|
|
 |
1,1-Dimethylethyl 10,10-dimethyl-8-oxo-3,9-dioxa-2,7-diazaundecanoate |
1243021-74-0 |
C13H26N2O5 |
 |
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla |
99696-21-6 |
C15H12ClF2NO3 |
 |
2'-DEOXYCYTIDINE MONOHYDRATE, 99+% |
652157-52-3 |
C9H15N3O5 |
 |
tert-butyl (3R,6S)-3-((tert-butoxycarbonyl)((tert-butyldimethylsilyl)oxy)amino) -6-carbamoyl -5-methyl-3,6-dihydropyridine-1(2H)-carboxylate |
2209874-00-8 |
C23H43N3O6Si |
 |
5-Pyrimidinamine, 2-nitro- (9CI) |
123770-64-9 |
C4H4N4O2 |
![(3S)-3-(Boc-amino)-2-hydroxy-4-[(S)-2-oxo-3-pyrrolidinyl]butanenitrile](/CAS/20211123/GIF/2755780-15-3.gif) |
(3S)-3-(Boc-amino)-2-hydroxy-4-[(S)-2-oxo-3-pyrrolidinyl]butanenitrile |
2755780-15-3 |
C13H21N3O4 |